Aiming for zero tuberculosis transmission in low-burden countries,The Lancet Respiratory Medicine

当前位置： X-MOL 学术 › Lancet Respir. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Aiming for zero tuberculosis transmission in low-burden countries
The Lancet Respiratory Medicine ( IF 76.2 ) Pub Date : 2017-10-12 , DOI: 10.1016/s2213-2600(17)30382-x
Ben J Marais ₁ , Timothy M Walker ₂ , Daniela M Cirillo ₃ , Mario Raviglione ₄ , Ibrahim Abubakar ₅ , Marieke J van der Werf ₆ , Catharina Boehme ₇ , Stefan Niemann ₈ , Kenneth G Castro ₉ , Alimuddin Zumla ₁₀ , Vitali Sintchenko ₁₁ , Derrick W Crook ₁₂

Affiliation

The Centre for Research Excellence in Tuberculosis, University of Sydney, NSW, 2145, Australia; Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, NSW, 2145, Australia.
National Institutes of Health Research Oxford Biomedical Research Centre, University of Oxford and the Department of Microbiology and Infectious Disease, Oxford University Hospitals National Health Service (NHS) Trust, Oxford, UK.
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
Global TB Programme, WHO, Geneva, Switzerland.
Institute for Global Health, University College London, London, UK.
European Centre for Disease Prevention and Control, Stockholm, Sweden.
Foundation for Innovative New Diagnostics, Geneva, Switzerland.
Molecular and Experimental Mycobacteriology, National Reference Center for Mycobacteria, Forschungszentrum and the German Center for Infection Research, Borstel, Germany.
Departments of Global Health and Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Center for Clinical Microbiology, Division of Infection and Immunity, University College London and National Institute for Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, NSW, 2145, Australia; NSW Mycobacterial Reference Laboratory, University of Sydney, NSW, 2145, Australia; Centre for Infectious Diseases and Microbiology-Public Health, University of Sydney, NSW, 2145, Australia.
National Institutes of Health Research Oxford Biomedical Research Centre, University of Oxford and the Department of Microbiology and Infectious Disease, Oxford University Hospitals National Health Service (NHS) Trust, Oxford, UK; National Infection Service, Public Health England, London, UK.

The End TB Strategy, approved by the World Health Assembly in May 2014, proposes ambitious targets to reduce the global burden of tuberculosis (TB).¹ The strategy calls for all governments to show high-level political commitment, including those of high-income countries with a low burden of disease. The framework for TB elimination in low-incidence countries, launched at the World TB Conference in 2015, challenged low-burden countries to aim for TB elimination (defined as <1 incident case of TB per million population) by 2035 or earlier.

中文翻译：

力争在低负担国家实现零结核病传播

2014 年 5 月世界卫生大会批准的终结结核病战略提出了减少全球结核病负担的雄心勃勃的目标。¹该战略呼吁所有政府，包括疾病负担低的高收入国家，表现出高水平的政治承诺。在 2015 年世界结核病大会上启动的低发病率国家消除结核病框架对低负担国家提出了挑战，以期在 2035 年或更早之前消除结核病（定义为每百万人口中少于 1 例结核病病例）。

更新日期：2017-10-13

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文

全部期刊列表>>